Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
John Oludele Olanlokun, Folashade Abimbola Balogun & Olufunso Olabode Olorunsogo. (2021) Chemotherapeutic and prophylactic antimalarial drugs induce cell death through mitochondrial-mediated apoptosis in murine models. Drug and Chemical Toxicology 44:1, pages 47-57.
Read now
Read now
Javier Lezaun. (2018) The deferred promise of radical cure: pharmaceutical conjugations of malaria in the global health era. Economy and Society 47:4, pages 547-571.
Read now
Read now
Articles from other publishers (18)
Amina J. Yusuf, Musa I. Abdullahi, Ibrahim Nasir, Abdulmajeed Yunusa, Celestina O. Alebiosu & Abubakar A. Muhammad. (2023) Isolation and Characterization of Prophylactic Antimalarial Agents from Ochna kibbiensis Leaves. Drugs and Drug Candidates 2:1, pages 37-51.
Crossref
Crossref
J. Kevin Baird. 2023. Infectious Diseases. Infectious Diseases
155
173
.
Oscar Bate Akide Ndunge, Nicole Kilian & Mootaz M. Salman. (2022)
Cerebral Malaria and Neuronal Implications of
Plasmodium Falciparum
Infection: From Mechanisms to Advanced Models
. Advanced Science 9:36.
Crossref
Crossref
J. Kevin Baird. 2020. Encyclopedia of Sustainability Science and Technology. Encyclopedia of Sustainability Science and Technology
1
19
.
Sibusiso Alven & Blessing Aderibigbe. (2019) Combination Therapy Strategies for the Treatment of Malaria. Molecules 24:19, pages 3601.
Crossref
Crossref
J. Kevin Baird. (2019) 8-Aminoquinoline Therapy for Latent Malaria. Clinical Microbiology Reviews 32:4.
Crossref
Crossref
Michele D. Spring, Sathit Pichyangkul, Chanthap Lon, Panita Gosi, Kosol Yongvanichit, Utaiwan Srichairatanakul, Amporn Limsalakpeth, Chaiyaporn Chaisatit, Soklyda Chann, Sabaithip Sriwichai, Montida Auayapon, Suwanna Chaorattanakawee, Sheetij Dutta, Satharath Prom, Char Meng Chour, Douglas S. Walsh, Evelina Angov & David L. Saunders. (2016) Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study. Malaria Journal 15:1.
Crossref
Crossref
B.A. Aderibigbe & H.E. Mukaya. 2016. Nanoarchitectonics for Smart Delivery and Drug Targeting. Nanoarchitectonics for Smart Delivery and Drug Targeting
169
200
.
Geoffrey S. Dow, Jun Liu, Gina Lin, Brian Hetzell, Sarah Thieling, William F. McCarthy, Douglas Tang & Bryan Smith. (2015) Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries. Malaria Journal 14:1.
Crossref
Crossref
Ian M Hastings & Eva Maria Hodel. (2014) Pharmacological considerations in the design of anti-malarial drug combination therapies – is matching half-lives enough?. Malaria Journal 13:1.
Crossref
Crossref
Geoffrey S Dow, William F McCarthy, Mark Reid, Bryan Smith, Douglas Tang & G Dennis Shanks. (2014) A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area. Malaria Journal 13:1.
Crossref
Crossref
Jason C. Sousa, Erin Milner, Dustin Carroll, William McCalmont, Sean Gardner, Jay Moon, Jacob D. Johnson, Patricia Lee, Jennifer Auschwitz, Norma Roncal, Diana Caridha, Anchalee Tungteung, Qiang Zeng, Sean Reyes, Bryan Smith, Qigui Li, Michael P. Kozar, Victor Melendez & Geoffrey Dow. (2014) The use of a prodrug approach to minimize potential CNS exposure of next generation quinoline methanols while maintaining efficacy in in vivo animal models. European Journal of Drug Metabolism and Pharmacokinetics 39:4, pages 231-236.
Crossref
Crossref
Geoffrey S Dow, Montip Gettayacamin, Pranee Hansukjariya, Rawiwan Imerbsin, Srawuth Komcharoen, Jetsumon Sattabongkot, Dennis Kyle, Wilbur Milhous, Simon Cozens, David Kenworthy, Anne Miller, Jim Veazey & Colin Ohrt. (2011) Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Malaria Journal 10:1.
Crossref
Crossref
Geoffrey S Dow, Erin Milner, Ian Bathurst, Jayendra Bhonsle, Diana Caridha, Sean Gardner, Lucia Gerena, Michael Kozar, Charlotte Lanteri, Anne Mannila, William McCalmont, Jay Moon, Kevin D Read, Suzanne Norval, Norma Roncal, David M Shackleford, Jason Sousa, Jessica Steuten, Karen L White, Qiang Zeng & Susan A Charman. (2011) Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice. Malaria Journal 10:1.
Crossref
Crossref
Erin Milner, Jason Sousa, Brandon Pybus, Victor Melendez, Sean Gardner, Kristina Grauer, Jay Moon, Dustin Carroll, Jennifer Auschwitz, Montip Gettayacamin, Patricia Lee, Susan Leed, William McCalmont, Suzanne Norval, Anchalee Tungtaeng, Qiang Zeng, Michael Kozar, Kevin D. Read, Qigui Li & Geoffrey Dow. (2011) Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum. European Journal of Drug Metabolism and Pharmacokinetics 36:3, pages 151-158.
Crossref
Crossref
Joseph J. Campo, Timothy J. Whitman, Daniel Freilich, Timothy H. Burgess, Gregory J. Martin & Denise L. Doolan. (2011) Toward a Surrogate Marker of Malaria Exposure: Modeling Longitudinal Antibody Measurements under Outbreak Conditions. PLoS ONE 6:7, pages e21826.
Crossref
Crossref
Dongzhen Yu, Dalian Ding, Haiyan Jiang, Daniel Stolzberg & Richard Salvi. (2010) Mefloquine Damage Vestibular Hair Cells in Organotypic Cultures. Neurotoxicity Research 20:1, pages 51-58.
Crossref
Crossref
Susan Fracisco, James F. Cummings, Gregory A. Deye, Colin Ohrt, Donna Tosh, James E. Moon, R. Scott Miller, Lori Miller & Alan J. Magill. (2011) Plasmodium falciparum Infection during Suppressive Prophylaxis with Mefloquine Does Not Induce an Antibody Response to Merozoite Surface Protein-1(42). The American Journal of Tropical Medicine and Hygiene 84:5, pages 825-829.
Crossref
Crossref